Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Nov 7, 2019, before the open
10-Q filed Nov 7, 2019, 38 days after period end · 0001564590-19-041774
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | — | $18.82M | — | — |
| Net Income | -$4.65M | $11.54M | -$4.65M | -$4.89M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.11 |
| $0.28 |
| -$0.17 |
| -$6.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.